Your browser doesn't support javascript.
loading
Artificial Intelligence-Based Mitosis Scoring in Breast Cancer: Clinical Application.
Ibrahim, Asmaa; Jahanifar, Mostafa; Wahab, Noorul; Toss, Michael S; Makhlouf, Shorouk; Atallah, Nehal; Lashen, Ayat G; Katayama, Ayaka; Graham, Simon; Bilal, Mohsin; Bhalerao, Abhir; Ahmed Raza, Shan E; Snead, David; Minhas, Fayyaz; Rajpoot, Nasir; Rakha, Emad.
Afiliación
  • Ibrahim A; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Department of Pathology, Faculty of Medicine, Suez Canal University, Egypt.
  • Jahanifar M; Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Wahab N; Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Toss MS; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Histopathology Department, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Makhlouf S; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Atallah N; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Lashen AG; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Katayama A; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Graham S; Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Bilal M; Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Bhalerao A; Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Ahmed Raza SE; Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Snead D; Cellular Pathology, University Hospitals Coventry and Warwickshire NHS Trust, United Kingdom.
  • Minhas F; Tissue Image Analytics Centre, University of Warwick, United Kingdom.
  • Rajpoot N; Tissue Image Analytics Centre, University of Warwick, United Kingdom. Electronic address: n.m.rajpoot@warwick.ac.uk.
  • Rakha E; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; Pathology Department, Hamad Medical Corporation, Doha, Qatar. Electronic address: emad.rakha@nottingham.a
Mod Pathol ; 37(3): 100416, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38154653
ABSTRACT
In recent years, artificial intelligence (AI) has demonstrated exceptional performance in mitosis identification and quantification. However, the implementation of AI in clinical practice needs to be evaluated against the existing methods. This study is aimed at assessing the optimal method of using AI-based mitotic figure scoring in breast cancer (BC). We utilized whole slide images from a large cohort of BC with extended follow-up comprising a discovery (n = 1715) and a validation (n = 859) set (Nottingham cohort). The Cancer Genome Atlas of breast invasive carcinoma (TCGA-BRCA) cohort (n = 757) was used as an external test set. Employing automated mitosis detection, the mitotic count was assessed using 3 different methods, the mitotic count per tumor area (MCT; calculated by dividing the number of mitotic figures by the total tumor area), the mitotic index (MI; defined as the average number of mitotic figures per 1000 malignant cells), and the mitotic activity index (MAI; defined as the number of mitotic figures in 3 mm2 area within the mitotic hotspot). These automated metrics were evaluated and compared based on their correlation with the well-established visual scoring method of the Nottingham grading system and Ki67 score, clinicopathologic parameters, and patient outcomes. AI-based mitotic scores derived from the 3 methods (MCT, MI, and MAI) were significantly correlated with the clinicopathologic characteristics and patient survival (P < .001). However, the mitotic counts and the derived cutoffs varied significantly between the 3 methods. Only MAI and MCT were positively correlated with the gold standard visual scoring method used in Nottingham grading system (r = 0.8 and r = 0.7, respectively) and Ki67 scores (r = 0.69 and r = 0.55, respectively), and MAI was the only independent predictor of survival (P < .05) in multivariate Cox regression analysis. For clinical applications, the optimum method of scoring mitosis using AI needs to be considered. MAI can provide reliable and reproducible results and can accurately quantify mitotic figures in BC.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Egipto

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Mod Pathol Asunto de la revista: PATOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Egipto